Oneness Biotech Co., Ltd. (TPEX:4743)
50.40
+0.70 (1.41%)
May 29, 2026, 1:30 PM CST
Oneness Biotech Revenue
Oneness Biotech had revenue of 36.62M TWD in the quarter ending March 31, 2026, with 45.21% growth. This brings the company's revenue in the last twelve months to 140.52M, up 19.77% year-over-year. In the year 2025, Oneness Biotech had annual revenue of 129.12M with 9.49% growth.
Revenue (ttm)
140.52M
Revenue Growth
+19.77%
P/S Ratio
171.87
Revenue / Employee
3.27M
Employees
43
Market Cap
24.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 129.12M | 11.20M | 9.49% |
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.04B |
| EirGenix | 1.13B |
| Ever Supreme Bio Technology | 1.03B |
| Medigen Vaccine Biologics | 603.68M |
| TaiMed Biologics | 601.19M |
| Polaris Group | 69.27M |
| AP Biosciences | 32.25M |
| Lumosa Therapeutics | 31.42M |